Biobijou Co

Biobijou Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biobijou Co (489460.KQ) as of Nov 5, 2026 is 4.23 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 9.48 B KRW — a change of -55.40% (lower).

EBITDA

4.23 BKRW

YoY

-55.40%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biobijou Co is 2025 4.23 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biobijou Co was 2024 9.48 B KRW. It decreases by -55.40% lower compared to the previous year.

The Biobijou Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2022
3.64 B KRW
Jan 1, 2023
5.32 B KRW
Jan 1, 2024
9.48 B KRW
Jan 1, 2025
4.23 B KRW
The Biobijou Co EBITDA history
YEAREBITDAYoY
4.23 BKRW-55.40%
9.48 BKRW+78.15%
5.32 BKRW+46.20%
3.64 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biobijou Co Stock analysis

What does Biobijou Co do? Biobijou Co Ltd is a South Korean pharmaceutical company based in Hanam, Gyeonggi-Do, operating within the Health Care sector. The company focuses on the research, development, manufacturing, and sale of skin booster and filler products utilizing hyaluronic acid and various materials for the global aesthetic market. It also produces cosmetic products including masks, mists, and creams. Biobijou Co Ltd completed its initial public offering on May 20, 2025, with the ticker symbol 489460.KQ and ISIN KR74860006. The company's website is http://www.biobijou.co.kr. It operates as an export-oriented business, targeting international markets for its aesthetic and cosmetic product lines. The firm's primary activities involve the production and distribution of hyaluronic acid-based skin care solutions and related cosmetic items. As a newly listed entity, Biobijou Co Ltd is positioned within the pharmaceutical and cosmetic industries, emphasizing innovation in aesthetic treatments. The company's operations are centered in Hanam, South Korea, with an emphasis on global market expansion through its export strategy. Biobijou Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biobijou Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biobijou Co is 4.23 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biobijou Co changed from 9.48 B KRW to 4.23 B KRW, representing a -55.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Biobijou Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Biobijou Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Biobijou Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Biobijou Co